Answer
Based on its pharmacodynamic and pharmacokinetic profile, tafamidis meglumine is believed to have no or negligible influence on the ability to drive or use machines.
Sources for this answer
- Vyndaqel 20 mg soft capsulesPfizer Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 18Document updated
Sources checked